Max W. Sung
Cornell University(US)Weill Cornell Medicine(US)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma(2020)1,150 cited
- → The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies(2009)529 cited
- → Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis(2004)459 cited
- → Long-Term Results With Multimodal Adjuvant Therapy and Liver Transplantation for the Treatment of Hepatocellular Carcinomas Larger Than 5 Centimeters(2002)385 cited
- → Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials(2002)255 cited
- → First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma(2019)244 cited